HomeBUSINESS
BUSINESS

Kirin, Amgen Wind Up Drug Development Joint Venture
(Nov.2.2017)

Kirin Holdings and Amgen will dissolve their drug development joint venture, making the three-decade-old firm a wholly owned subsidiary of the US biotech giant, the two companies have announced ...
(LOG IN FOR FULL STORY)

News Calendar